Hollie Bartley is the Group Lead for Process Development at Resolution Therapeutics, a UK biopharmaceutical company developing engineered macrophage therapies for end-stage liver disease. Prior to joining Resolution Therapeutics, Hollie spent four years at Achilles Therapeutics and two years at University College London. In these roles she has developed skills in GMP manufacturing, Quality Control, Quality Assurance and product development of ATMPs from bench to bedside. Currently, she focusses on continuing development from early phase trials to commercial launch of investigational products.